Popular search terms:
Search Results
30 results found-
R&D Investor Briefing 2015
Factors that could cause actual results to differ materially include: the success of research and development activities, decisions by regulatory authorities regarding approval of
https://www.cslbehring.ca/-/media/shared/documents/7/rd-investor-briefing-2015.pdf -
R&D Investor Briefing 2014
Factors that could cause actual results to differ materially include: the success of research and development activities, decisions by regulatory authorities regarding approval of
https://www.cslbehring.ca/-/media/shared/documents/7/rd-investor-briefing-2014.pdf -
R&D Investor Briefing 2017
Factors that could cause actual results to differ materially include: the success of research and development activities, decisions by regulatory authorities regarding approval of
https://www.cslbehring.ca/-/media/shared/documents/7/rd-investor-briefing-2017.pdf -
R&D Investor Briefing 2016
Factors that could cause actual results to differ materially include: the success of research and development activities, decisions by regulatory authorities regarding approval of
https://www.cslbehring.ca/-/media/shared/documents/7/rd-investor-briefing-2016.pdf -
Product Pipeline
Our continued growth. Our balanced research and development portfolio is divided into three categories: life cycle management, market development and new product development.
https://www.cslbehring.ca/r-and-d/product-pipeline -
Corporate Responsible Business Practice
CODE GLOSSARY 3. SAFETY AND QUALITY OF OUR PRODUCTS 28 3.1 Bioethics 30 3.1.1 Research and development 30 3.1.2 Clinical trials 30 3.1.3 Stem cell research 31 3.1.4 Animal welfare
https://www.cslbehring.ca/-/media/csl/documents/crbp-languages/csl_crbp17i_english.pdf -
Out of the Lab, Into the Business World
Dr. Andrea Douglas of CSL Behring discusses bringing women into STEM fields and raising them to the executive ranks.
https://www.cslbehring.ca/news/2018/20180124-women-in-stem